Bevacizumab BS IV infusion 100mg “Pfizer” is a biosimilar of bevacizumab (genetical recombination), manufactured by Pfizer. This injectable drug (YJ code: 4291449A1020) is supplied as 100mg in 4mL per bottle, used to treat various cancers including metastatic colorectal cancer, non-small cell lung cancer, and kidney cancer.
Bevacizumab BS IV infusion 100mg “Pfizer”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →